行情

OXFD

OXFD

Oxford Immunotec
NASDAQ

实时行情|Nasdaq Last Sale

9.54
-0.15
-1.55%
已收盘, 16:00 04/03 EDT
开盘
9.74
昨收
9.69
最高
10.30
最低
9.45
成交量
45.42万
成交额
--
52周最高
17.77
52周最低
8.37
市值
2.50亿
市盈率(TTM)
-183.8150
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测OXFD价格均价为20.00,最高价位21.00,最低价为19.00。

EPS

OXFD 新闻

更多
  • 德国今年经济或因疫情萎缩3-6%
  • 新浪财经 · 1小时前
  • 亚太股市因疫情放缓希望而大涨,多个股指进入技术性牛市
  • 环球外汇网 · 1小时前
  • 3M称特朗普批评大错特错,不会停止向加拿大和拉美出口口罩
  • 澎湃新闻 · 1小时前
  • 土豪国也撑不住:迪拜最大地产公司全员减薪
  • 新浪财经 · 1小时前

所属板块

先进医疗设备和技术
-1.50%
医疗设备和用品
-1.17%

热门股票

代码
价格
涨跌幅

OXFD 简况

Oxford Immunotec Global PLC,is a diagnostics company. It is focused on developing and commercializing tests for under-served immune-regulated conditions. Its product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. It offers a range of assays for tick-borne diseases, such as Lyme disease, obtained through the acquisitions of Imugen and Immunetics. Tick-borne disease is the collective name for diseases passed to humans through the bite of an infected tick. Its diagnostic tests for tick-borne infections include multiple laboratory developed tests (LDTs). Its tick-borne disease tests utilize molecular methods (such as polymerase chain reaction) and techniques to prosecute the immune system. It has a series of assays for use in blood screening, building upon its expertise in tick-borne disease.
展开

微牛提供Oxford Immunotec Global PLC(NASDAQ-OXFD)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的OXFD股票新闻,以帮助您做出投资决策。